[1] |
LUO Lingling, CUI Pangen. Update of tumor necrosis factor inhibitor for the treatment of non-psoriatic skin diseases [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 698
-700,704
. |
[2] |
WANG Xiaoling, FU Fanghui, FU Xi’an , SUN Lele, YU Gongqi, LIU Hong, ZHANG Furen. Mutation detection in two epidermolytic palmoplantar keratosis families[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(12): 715
-717
. |
[3] |
YU Liang, GAO Min, ZHANG Xuejun. Psoriasis and the risk of major cardiovascular events[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(10): 631
-633
. |
[4] |
DENG Yue, LIU Haidong, ZHUANG Le, MA Weiyuan. Expression of eIF4E in basal cell carcinoma[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 388
-390
. |
[5] |
ZENG Chenglong, FENG Ting, YAN Dan, WANG Shengchun. Comparison of SAT, Liquid culture and PCR in detection of ureaplasma urealyticum[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 397
-398
. |
[6] |
XU Yu, WANG Zaixing, DOU Jinfa, YANG Sen. Update of ERAP1 and psoriasis[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 439
-441
. |
[7] |
ZENG Lei, FU Liying, WANG Peiguang. Update of study in pityriasis rubra pilaris[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 442
-445
. |
[8] |
LANG Xiaoqiao, SUN Yonghu, FU Xi'an, SUN Lele, LIU Hong, ZHANG Furen . Mutation analysis in three cases with sporadic neurofibromatosis type 1[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(1): 9
-12
. |
[9] |
LI Buyan, LU Xianmei, SUN Yonghu, ZHOU Guizhi, CHEN Shengli, LIU Yongxia, CHEN Xuechao, WANG Jianwen, ZHANG Furen. Clinical and pathological analysis of 36 cases with granulomatous chellitis[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(1): 13
-16
. |
[10] |
SHI Jianfei, CHEN Xiaodong. Effect of Shuxuetong injection on the expression of MMP-2 and ɑ-SMA in hypertrophic scars of rabbit ear[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(1): 20
-24
. |
|